CBGL (Cannabis Global) ROE % Adjusted to Book Value: -113.34% (As of May. 2022)


What is Cannabis Global ROE % Adjusted to Book Value?

Cannabis Global CBGL ROE % Adjusted to Book Value is -113.34% as of May. 2022.

Cannabis Global's ROE % for the quarter that ended in May. 2022 was -56.67%. Cannabis Global's PB Ratio for the quarter that ended in May. 2022 was 0.50. Cannabis Global's ROE % Adjusted to Book Value for the quarter that ended in May. 2022 was -113.34%.

Cannabis Global ROE % Adjusted to Book Value Related Terms

Cannabis Global ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Cannabis Global's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannabis Global ROE % Adjusted to Book Value Chart

Cannabis Global Annual Data
Trend Aug12 Aug13 Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cannabis Global Quarterly Data
Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 Negative Equity -201.29 -113.34

CBGL vs MILC, BBBT, GCAN: ROE % Adjusted to Book Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Global's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannabis Global ROE % Adjusted to Book Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Global's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Cannabis Global's ROE % Adjusted to Book Value falls into.


Cannabis Global ROE % Adjusted to Book Value Calculation

Cannabis Global's ROE % Adjusted to Book Value for the fiscal year that ended in Aug. 2021 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Cannabis Global's ROE % Adjusted to Book Value for the quarter that ended in May. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-56.67% / 0.50
=-113.34%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -113.34% mean?
Cannabis Global (CBGL) has a ROE % Adjusted to Book Value of -113.34% as of May. 2022. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Cannabis Global and its competitors.
Is Cannabis Global's ROE % Adjusted to Book Value too high?
Cannabis Global's current ROE % Adjusted to Book Value is -113.34%.
How does Cannabis Global's ROE % Adjusted to Book Value compare to MILC and BBBT?
Cannabis Global's ROE % Adjusted to Book Value of -113.34% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Cannabis Global and its competitors. Cannabis Global's current ROE % Adjusted to Book Value is -113.34%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabis Global stock overvalued right now?
Cannabis Global (CBGL) has a current ROE % Adjusted to Book Value of -113.34%. The current ROE % Adjusted to Book Value is -113.34%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Cannabis Global (CBGL), the current ROE % Adjusted to Book Value is -113.34% as of May. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cannabis Global Business Description

Address 520 S Grand Avenue, Suite 320, Los Angeles, CA, USA, 90071
Cannabis Global Inc manufactures and distributes various cannabis products via its majority ownership of Natural Plant Extract, Inc is developing the Ethos Comply Bag, and generally conducts research and development in the areas of hemp, cannabis and consumer food goods. The company also have an active research and development program focused on creating and commercializing engineered technologies that deliver hemp extracts and cannabinoids to the human body. Its product includes cannabis flower packaged in various weights, cannabis Pre-rolls, cannabis edible products.